Antidepressant mechanism of ketamine: perspective from preclinical studies

A debilitating mental disorder, major depressive disorder is a leading cause of global disease burden. Existing antidepressant drugs are not adequate for the majority of depressed patients, and large clinical studies have demonstrated their limited efficacy and slow response onset. Growing evidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheuing, Lisa, Chiu, Chi-Tso, Liao, Hsiao-Mei, Chuang, De-Maw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508505/
https://www.ncbi.nlm.nih.gov/pubmed/26257598
http://dx.doi.org/10.3389/fnins.2015.00249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508505/
https://www.ncbi.nlm.nih.gov/pubmed/26257598
http://dx.doi.org/10.3389/fnins.2015.00249

Ejemplares similares